The Ashwin is a monthly webzine for
ΑΩ Labs' customers -- April, 2002 Edition
Formatted to 600 pixel width for ease of reading and hardcopy reproduction
from the browser.
Related Links:
Ashwin Archives
Letters to the Editor - (Submissions)
|
|
Meeker Raspberries...
... provide the source material for the extract
from which we provide our ellagic acid.
Immune Builders
Take Center Stage
ast month
theme was cardiovascular health - so we announced the creation of a
"Healthy Heart" page
(March issue). In that addition,
we introduced our own flax product,
AO Heart Drops (with a long history
of relief for heart disease and stroke patients), and a proprietary product
from the U.S. called Medicardium - which
allows people to obtain, without needles and without time-consuming
clinical visits, the benefits of chelation therapy.
The theme of this month's
new introductions is Immune Building, an area we have
begin to focus on in order to make our internal Cansema
and CanSupport products even more effect. (This is now
expressed in a small section
in the lower right column
of Cansema page.)
The new additions
include Co-Q-10,
Beta 1,3-D Glucan, and
ellagic acid (from Meeker
raspberry extract). We are also drawing attention to
Agaricus mushroom extract,
which was first introduced in the
February issue of this ezine,
for its immune building properties.
Scalar Wave &
Advances in "Vibrational" Medicine
We first discussed
our use of scalar wave technology in the
November, 2001 issue of
this publication. Later, we added sections of an
interview we had with world-noted authority,
Dr. Tom Beardon
to our video section. We were going to cover
this area, in practical terms, in greater depth
this issue, but have decided, instead, in the
name of thoroughness, to leave this product
for June - when we will be introducing our
own energy machine (for research purposes).
At that point,
we will provide our own presentation on the difference
between Rife technology and the later contributions
of John Crane - and how both differ from scalar
wave generation.
Two quick points on our
FAQ pages. Some have written us to ask why FAQ pages are not
posted at the same time that products are introduced.
Our reasoning is that FAQ pages (FAQ - as you probably know,
short for "Frequently Asked Questions") are designed to answer
the mostly frequented asked questions that customers have
and save on email queries. Well-constructed
FAQ pages save time for both users and the
principals behind the web sites they visit.
We want our FAQ pages
to reflect actual questions that repeatedly arise from end
users, not provide more fluff that customers have to
wade through.
On a different note,
it continues to be our experience that 80% of all customer
service questions are clearly answered in the
FAQ section, which means that
many people do not take the time to read the information
we have before asking questions.
For this reason, we
are our customers, particularly those ordered from the
established product lines: Cansema, CanSupport,
Bloodroot Paste, QuikHeal, etc. - to check the FAQ section
before sending off an inquiry.
Again, it serves to
save both of us time and effort.
|
Note to our Readers:
This is the seventh edition of the The Ashwin
(pronounced "Ah-sh' win"), covering April, 2002.
Previous editions are archived.
If you have questions,
email us.
|
urns & Wounds (B&W) Ointment is the newest
topical formula to be added at AO Labs. In addition to
QuikHeal ozonated salves and
H3O, users now another choice
to quicken the "heal over" phase of escharization.
B & W Ointment has
traditionally been used within the Amish community to
treat burns. The extensive use of wood-burning stoves,
gas lamps, and other simple, low-tech, heat-generating
tools and devices in that community has brought about
a need for a simple, easy-to-apply topical that will
quickly ease pain and expedite healing. One Amish
physician developed B & W years ago precisely for that
purpose and it is quite popular.
This month we make
it available for our customers.
Warning
About
Imitation
Web Site
One of our vendors in the
United States alerted Alpha Omega Labs about an "imitation web site"
earlier this week (4/10/02) called Phoenix Cure
(www.phoenixcure.com). The primary purpose of our bringing
this up is to serve notice to the public that Alpha Omega
Labs is in no way associated with this organization -
or the ex-AO associate, George Ackerson, who is similarly
imitating some of our work.
This isn't an issue
of competitive pettiness. It is an issue of legal requirement.
Not only does the "Phoenix" web site
blatantly violate Alpha Omega's copyrights by
having lifted entire pages -- images and all --
from this site, but it massively violates United
States Food & Drug law. The site promises complete
"cancer cures," encourages readers to avoid conventional
therapy at all costs (something we regard we reckless),
and then proceeds to offer imitations of Alpha Omega Labs
products at 200-300% of the prices on this site.
Some of our trademarks are even used in the text,
interchangably with newly created names (i.e. "HRx").
A whois
at Verisign or other internet registrar shows that
the owner of the site is Phoenix Cure International
and provides a foreign address of "Apartado 0832-2422,
World Trade Center, Panama." Moreover, the web host listed
is American Discount Web Hosting, located at
New Jersey. (Email: tech@adwh.com. Phone: 856-833-0999).
When we brought the
violations to the attention of the host, we received an email
back from a "Bill Nash" indicating that he was aware that
the site was "cheating" the public, but that, in so many
words, he didn't intend to do anything about it.
We intend to take
other measures -- but in the interim, in it important
to publish distance ourselves from Phoenix Cure,
or anyone else who makes these horrific and
unjustifiable representations.
Late Note: (5/4/02) > Under pressure from another party
in Austin, Texas, who also had copyright infringement
issues with the phoenixcure.com web site,
this site was recently shut down.
|
Home Page |
Order
© 2001-2002 Alpha Omega Labs • Nassau, Bahamas • All
rights reserved. This page posted : 03/31/2002
and updated 04/09/2002 and finally
05/04/2002.
|